ABVC BioPharma, Inc.
ABVC
$1.00
-$0.06-5.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 67.35% | -85.27% | -387.00% | -215.73% | -139.52% |
| Total Depreciation and Amortization | 10.77% | -19.05% | 274.98% | -9.77% | -29.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.66% | 232.51% | 335.55% | 312.42% | 272.77% |
| Change in Net Operating Assets | 154.55% | -503.11% | 76.65% | -348.74% | -309.81% |
| Cash from Operations | 72.67% | -65.65% | -102.11% | -321.43% | -322.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.76% | -- | 59.87% | -2,942.41% | -32.74% |
| Cash from Investing | 84.76% | -- | 59.87% | -2,942.41% | -32.74% |
| Total Debt Issued | 1,608.89% | -- | 569.15% | 122.27% | -98.99% |
| Total Debt Repaid | 60.05% | -2,158.36% | 38.59% | -87.44% | -- |
| Issuance of Common Stock | -100.00% | 2.38% | 592.27% | 70.92% | 1,456.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 320.30% | -320.30% | -- | -- | 78.76% |
| Cash from Financing | -88.26% | -179.80% | 242.32% | 1,491.15% | 140.25% |
| Foreign Exchange rate Adjustments | 122.53% | -61.76% | 248.57% | 1,423.53% | -837.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.22% | -1,038.87% | 403.83% | -920.66% | 278.04% |